1. 283 Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors (ICIs). (9th November 2020) Authors: Pant, Shubham; Shah, Amishi; Msaouel, Pavlos; Campbell, Matthew; Tu, Shi-Ming; Gao, Jianjun; Blumenschein, George; Mott, Frank; Le, Xiuning; Altan, Mehmet; Meric-Bernstam, Funda; Yap, Timothy; Subbiah, Vivek; Rodon, Jordi; Glasmacher, Axel; Mulder, Imke; Chisamore, Michael; Stevenson, Alexander; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 376 A phase I/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors. (9th November 2020) Authors: Pant, Shubham; Shah, Amishi; Msaouel, Pavlos; Campbell, Matthew; Tu, Shi-Ming; Gao, Jianjun; Blumenschein, George; Mott, Frank; Le, Xiuning; Altan, Mehmet; Meric-Bernstam, Funda; Yap, Timothy; Subbiah, Vivek; Rodon, Jordi; Glasmacher, Axel; Mulder, Imke; Chisamore, Michael; Stevenson, Alexander; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 441 Outcomes of patients with metastatic renal cell carcinoma with intermediate- or poor-risk symptomatic disease who received their first cycle of nivolumab and ipilimumab while being hospitalized. (9th November 2020) Authors: Alhalabi, Omar; Hasanov, Elshad; Araujo, John; Wang, Jianbo; Campbell, Matthew; Goswami, Sangeeta; Shah, Amishi; Gao, Jianjun; Msaouel, Pavlos; Tannir, Nizar Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes. (1st March 2021) Authors: Laccetti, Andrew L.; Garmezy, Benjamin; Xiao, Lianchun; Economides, Minas; Venkatesan, Aradhana; Gao, Jianjun; Jonasch, Eric; Corn, Paul; Zurita‐Saavedra, Amado; Brown, Landon C.; Kao, Chester; Kinsey, Emily N.; Gupta, Rajan T.; Harrison, Michael R.; Armstrong, Andrew J.; George, Daniel J.; Tanni... Journal: Cancer medicine Issue: Volume 10:Number 7(2021) Page Start: 2341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events. Issue 7 (29th July 2021) Authors: Siddiqui, Bilal A; Gheeya, Jinesh S; Goswamy, Rohit; Bathala, Tharakeswara K; Surasi, Devaki Shilpa; Gao, Jianjun; Shah, Amishi; Campbell, Matthew T; Msaouel, Pavlos; Goswami, Sangeeta; Wang, Jennifer; Zurita, Amado J; Jonasch, Eric; Corn, Paul G; Aparicio, Ana M; Siefker-Radtke, Arlene O; Sharma... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Emerging treatments in advanced urothelial cancer. Issue 3 (May 2020) Authors: Alhalabi, Omar; Campbell, Matthew; Shah, Amishi; Siefker-Radtke, Arlene; Gao, Jianjun Journal: Current opinion in oncology Issue: Volume 32:Issue 3(2020:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LBA01-10 INTERIM RESULTS FROM A PHASE 1B CLINICAL TRIAL EVALUATING TOLERABILITY AND ACTIVITY OF FGFR INHIBITION IN LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA (UTUC). (May 2022) Authors: Matin, Surena; Adibi, Mehrad; Shah, Amishi; Alhalabi, Omar; Corn, Paul; Guo, Charles; Amirtharaj, Rhenita; Lozano, Marisa; Xiao, Lianchun; Pal, Sumanta; Campbell, Matthew Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Managing seminomatous and nonseminomatous germ cell tumors. Issue 3 (May 2018) Authors: Chahoud, Jad; Zhang, Miao; Shah, Amishi; Lin, Sue-Hwa; Pisters, Louis L.; Tu, Shi-Ming Journal: Current opinion in oncology Issue: Volume 30:Issue 3(2018:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting advanced urothelial carcinoma-developing strategies. Issue 3 (May 2019) Authors: Alhalabi, Omar; Rafei, Hind; Shah, Amishi; Siefker-Radtke, Arlene; Campbell, Matthew; Gao, Jianjun Journal: Current opinion in oncology Issue: Volume 31:Issue 3(2019:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗